BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2774485)

  • 1. Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease.
    de la Monte SM
    Ann Neurol; 1989 May; 25(5):450-9. PubMed ID: 2774485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia.
    Tomimoto H; Lin JX; Matsuo A; Ihara M; Ohtani R; Shibata M; Miki Y; Shibasaki H
    J Neurol; 2004 Apr; 251(4):398-406. PubMed ID: 15083283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
    Doddy RS; Massman PJ; Mawad M; Nance M
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphometric and pathologic studies of the brain in autopsied cases of Alzheimer-type dementia].
    Nishimura A; Fujiwara S; Mizoi Y; Tatsuno Y
    Nihon Hoigaku Zasshi; 1992 Apr; 46(2):141-51. PubMed ID: 1619811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterogeneity of Alzheimer's disease].
    Scheltens P; Vermersch P; Leys D
    Rev Neurol (Paris); 1993; 149(1):14-25. PubMed ID: 8337557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of gliosis in Alzheimer's disease and aging cerebrum.
    Beach TG; Walker R; McGeer EG
    Glia; 1989; 2(6):420-36. PubMed ID: 2531723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways.
    Hof PR; Vogt BA; Bouras C; Morrison JH
    Vision Res; 1997 Dec; 37(24):3609-25. PubMed ID: 9425534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease--a neuropathological study.
    Sjöbeck M; Haglund M; Englund E
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):919-26. PubMed ID: 16163742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
    Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
    Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease with and without cerebral infarcts.
    Del Ser T; Hachinski V; Merskey H; Munoz DG
    J Neurol Sci; 2005 Apr; 231(1-2):3-11. PubMed ID: 15792814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is hippocampal atrophy a specific change for Alzheimer's disease?].
    Hanyu H; Asano T; Sakamoto S; Kogure D; Iwamoto T; Takasaki M
    No To Shinkei; 1999 Nov; 51(11):947-51. PubMed ID: 10586410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated method for identification of patients with Alzheimer's disease based on three-dimensional MR images.
    Arimura H; Yoshiura T; Kumazawa S; Tanaka K; Koga H; Mihara F; Honda H; Sakai S; Toyofuku F; Higashida Y
    Acad Radiol; 2008 Mar; 15(3):274-84. PubMed ID: 18280925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.
    Brun A; Englund E
    Ann Neurol; 1986 Mar; 19(3):253-62. PubMed ID: 3963770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease.
    van Es AC; van der Flier WM; Admiraal-Behloul F; Olofsen H; Bollen EL; Middelkoop HA; Weverling-Rijnsburger AW; Westendorp RG; van Buchem MA
    Neurobiol Aging; 2006 Dec; 27(12):1757-62. PubMed ID: 16290268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy.
    Lerch JP; Pruessner JC; Zijdenbos A; Hampel H; Teipel SJ; Evans AC
    Cereb Cortex; 2005 Jul; 15(7):995-1001. PubMed ID: 15537673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributors to white matter damage in the frontal lobe in Alzheimer's disease.
    Chalmers K; Wilcock G; Love S
    Neuropathol Appl Neurobiol; 2005 Dec; 31(6):623-31. PubMed ID: 16281911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.